Masiba, Veronica S.

HRN: 21-82-01  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/17/2022
CEFUROXIME 1.5GM (VIAL)
08/17/2022
08/24/2022
IV
1.5 Grams
Q8H
Surgical Prophylaxis; Fracture L Clavicle
Waiting Final Action 

Indication:  Prophylaxis    Type of Infection:  Bone & Joint    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: